Delphi Private Advisors’s ResMed RMD Stock Holding History

Delphi Private Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-21	Closed	-$1K	–	412
2016 Q3	$1K	Hold	21	–	–	﹤0.01%	393
2016 Q2	$1K	Buy	21 +20	+2,000%	+$1.18K	﹤0.01%	410
2016 Q1	$0	Hold	1	–	–	﹤0.01%	386
2015 Q4	$0	Buy	+1	New	+$56	﹤0.01%	409

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

Delphi Private Advisors's RMD Position: Q4 2016 in Review

Delphi Private Advisors sold out of ResMed (RMD) in Q4 2016, closing a stake of 21 shares — an estimated $1K sold.

Delphi Private Advisors first reported a position in RMD in Q4 2015 and held it in 4 quarters. The position peaked at $1K in Q3 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

Delphi Private Advisors reported no remaining ResMed position as of Q4 2016 after selling out during the quarter.
Delphi Private Advisors sold 21 ResMed shares in Q4 2016, an estimated $1K.
Delphi Private Advisors first reported a position in ResMed in Q4 2015 and held it in 4 quarters.
Delphi Private Advisors's ResMed position peaked at $1K in Q3 2016.
361 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on Delphi Private Advisors's 13F filing for Q4 2016, filed 31 Jan 2017.